APAM vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

APAM

34.2
AI Score
VS
APAM Wins

FHI

31.6
AI Score

Investment Advisor Scores

APAM

34score
Recommendation
SELL

FHI

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric APAM FHI Winner
Revenue 1.49B 923.44M FHI
Net Income 312.58M 214.06M FHI
Net Margin 21.0% 23.2% APAM
Operating Income 412.52M 288.61M FHI
ROE 24.2% 48.3% APAM
ROA 12.7% 14.1% APAM
Total Assets 2.47B 1.52B FHI
Debt/Equity 0.27 0.43 FHI
Free Cash Flow 223.93M 405.07M APAM

Relative Price Performance (Last 90 Days)

APAM 1M: +23.2% · 3M: -9.8% FHI 1M: +17.5% · 3M: +1.8%

Current Technical Phase

APAM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.8 · Price: $38.49

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 67

RSI (14): 66.9 · Price: $64.67

Fundamentals Snapshot

Metric APAM FHI
Market Cap — —
Forward P/E 10.8 10.8
Trailing P/E 9.4 11.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin 0.4% 0.3%
EPS 4.28 5.58
Dividend Yield 0.09% 0.02%

Frequently Asked Questions

Based on our detailed analysis, APAM is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.